Immunomodulators to igand icos variants and their uses

MA43551B1Active Publication Date: 2026-08-31ALPINE IMMUNE SCIENCES INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA43551
Authority / Receiving Office: MA · MA
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2017-04-14
Filing Date: 2017-04-14
Publication Date: 2026-08-31
Estimated Expiration: 2037-04-14

Application Information

Patent Timeline

14 Apr 2017

Priority

14 Apr 2017

Application

MA43551

31 Aug 2026

Publication

MA43551B1

IPC: C07K14/705

CPC: C07K14/70532; A61P1/04; A61P11/06; A61P17/06; A61P25/00; A61P27/02; A61P29/00; A61P35/00

Inventors: SWANSON Ryan; KORNACKER Michael

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to immunomodulatory proteins comprising variants of ICOSL, and nucleic acids encoding these proteins. Immunomodulatory proteins have a therapeutic utility for various immunological and oncological states. The present invention relates to compositions and methods for the manufacture and use of these proteins.

Need to check novelty before this filing date? Find Prior Art

Explore free tools for quick IP tasks

Patent Information

Abstract